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Short title: Peroxynitrite dilates cerebral arteries 
 
Abstract 
AIM: Increased thromboxane A2 and peroxynitrite are hallmarks of cerebral 
ischemia/reperfusion (I/R). Stimulation of thromboxane/prostaglandin receptors (TP) 
attenuates endothelium-derived hyperpolarization (EDH). We investigated whether EDH-
type middle cerebral artery (MCA) relaxations following TP stimulation are altered after I/R 
and the influence of peroxynitrite.  
METHODS: Vascular function was determined by wire myography after TP stimulation with 
the thromboxane A2 mimetic 9,11-Dideoxy-9α,11α-methano-epoxy prostaglandin F2α 
(U46619) in MCA of Sprague-Dawley rats subjected to MCA occlusion (90 min)/reperfusion 
(24 h) or sham operation, and in non-operated (control) rats. Some rats were treated with 
saline or the peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(4-
sulfonatophenyl)prophyrinato iron (III) (20 mg kg-1). Protein expression was evaluated in 
MCA and in human microvascular endothelial cells submitted to hypoxia 
(overnight)/reoxygenation (24 h) (H/R) using immunofluorescence and immunoblotting.  
RESULTS: In U46619-preconstricted MCA, EDH-type relaxation by the proteinase-activated 
receptor 2 agonist serine–leucine–isoleucine–glycine–arginine–leucine–NH2 (SLIGRL) was 
greater in I/R than sham rats due to an increased contribution of small-conductance calcium-
activated potassium channels (SKCa), which was confirmed by the enlarged relaxation to the 
SKCa activator N-cyclohexyl-N-2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine. I/R 
and H/R induced endothelial protein tyrosine nitration and filamentous-actin disruption. In 
control MCA, either cytochalasin D or peroxynitrite disrupted endothelial filamentous-actin 
and augmented EDH-type relaxation. Furthermore, peroxynitrite decomposition during I/R 
prevented the increase in EDH-type responses.  
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CONCLUSION: Following TP stimulation in MCA, EDH-type relaxation to SLIGRL is greater 
after I/R due to endothelial filamentous-actin disruption by peroxynitrite, which prevents TP-
induced block of SKCa input to EDH. These results reveal a novel mechanism whereby 
peroxynitrite could promote postischemic brain injury.  
 
Keywords: actin; calcium-activated potassium channels; ischemia/reperfusion; KCa2.3; 
SKCa; thromboxane 
 
Introduction 
The cerebrovasculature is continually exposed to various stimuli (e.g. high arterial pressure, 
ischemia) that can alter the physiological distribution of cerebral blood flow (CBF). Cerebral 
arteries possess mechanisms of autoregulation to maintain CBF and protect brain tissue 
during changes in perfusion pressure (Cipolla 2009). Both nitric oxide (NO) and 
endothelium-derived hyperpolarization (EDH) are two separate dilator pathways that operate 
simultaneously to regulate CBF. Several lines of evidence suggest that EDH-mediated 
responses persist or even increase when NO bioavailability is reduced in different 
pathological states, including cerebral ischemia-reperfusion (I/R; Marrelli et al. 1999, Marrelli 
2002, Cipolla et al. 2009). Compromised NO signalling is often associated with endothelial 
cell damage and platelet activation. Thus, EDH-mediated responses may act as a back-up 
mechanism to maintain endothelium-dependent vasodilation and homeostasis in the brain 
(Golding et al. 2002).  
Acute ischemic stroke is a thrombo-inflammatory disorder involving excessive platelet 
activation (Chamorro 2009). To date, immediate thrombolysis with tissue plasminogen 
activator is the only pharmacological treatment effective in ischemic stroke (George & 
Steinberg 2015), but it can develop into progressive damage in a process called “reperfusion 
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injury” (Coutts & Goyal 2009). Thromboxane A2 (TxA2) is one of the multiple factors released 
by activated platelets that can mediate further platelet recruitment, activation, and smooth 
muscle cell constriction, contributing to the prothrombotic state in I/R (Chamorro 2009). In 
addition, previous studies suggest a role of endothelial thromboxane/prostaglandin receptor 
(TP) stimulation in suppressing the small-conductance calcium-activated potassium (SKCa) 
channel component of EDH (Plane & Garland 1996, Crane & Garland 2004, McNeish & 
Garland 2007; McNeish et al. 2012, Gauthier et al. 2014). Thus, TxA2-induced attenuation of 
EDH-mediated relaxation may represent an additional mechanism by which TxA2 could 
impair tissue perfusion, especially in disease states where NO is defective (Ellinsworth et al. 
2014).  
TxA2 binds to TP in both smooth muscle and endothelial cells and triggers the RhoA/Rho 
kinase pathway, which is hyperactivated in the ischemic brain (Koumura et al. 2011), 
regulating many cellular functions including ion channel activity (Ghisdal et al. 2003, 
Luykenaar et al. 2009). Rho kinase activation is linked to inhibition of endothelial cell SKCa 
channel function in rat middle cerebral artery (MCA; McNeish et al. 2012, Gauthier et al. 
2014), although the precise mechanism is still unknown. One possibility is that inhibition of 
SKCa channel function is dependent upon actin cytoskeleton remodelling (Gorovoy et al. 
2005, Prasain & Stevens 2009). Therefore, we hypothesize that modulation of endothelial 
cell actin cytoskeleton is necessary for TP-dependent inhibition of SKCa channel function and 
EDH-type relaxation. Interestingly, I/R is associated with increased peroxynitrite formation 
and disruption of cerebral smooth muscle actin (Maneen et al. 2006, Maneen & Cipolla 
2007, Coucha et al. 2013). Therefore, we also explored whether peroxynitrite alters the 
endothelial actin cytoskeleton, and interferes with TP-dependent inhibition of SKCa channel 
function. Our results suggest that increased peroxynitrite production during I/R leads to 
endothelial cell F-actin disruption, which prevents TP-induced block of SKCa channel input to 
EDH, increasing proteinase-activated receptor (PAR) 2-evoked EDH-type relaxation. These 
findings reveal a novel mechanism whereby EDH may compensate loss of NO-mediated 
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relaxation in prothrombotic disease states such as ischaemic stroke. We propose that these 
alterations, however, could have potential deleterious effects on the injured brain. 
 
Materials and Methods 
Animals 
The animal studies are reported as recommended by the ARRIVE guidelines (Kilkenny et al. 
2010) and the study is conforming with: Good publication practice in physiology. Acta Physiol 
(Oxf). 2015 Dec;215(4):163-4. One hundred and thirty-five adult male Sprague-Dawley rats 
(Harlan; 270 to 330 g body weight) were used. Rats were housed under a 12:12-h light-dark 
cycle, controlled environmental conditions of temperature and humidity, and provided with 
access to food and water ad libitum. All of the experiments were carried out under the 
Guidelines established by the Spanish legislation (RD 1201/2005) and according to the 
guidelines for the European Community Council Directive (2010/63/EU) for Protection of 
Vertebrate Animals Used for Experimental and other Scientific Purposes. Experiments were 
approved by the Ethics Committee of the Universitat Autònoma de Barcelona.  
 
Transient middle cerebral artery occlusion model  
Rats were anesthetized with isoflurane (3.5%) in a mixture of O2 and N2O (30:70). Focal 
brain ischemia was produced by 90-min intraluminal occlusion of the right MCA with 
reperfusion (24 h) as reported previously (Pérez-Asensio et al. 2010, Onetti et al. 2015). 
Sham-operated (sham) rats were subjected to all the surgical procedures and the filament 
was introduced in the MCA and immediately removed. Cortical CBF, assessed with a laser–
Doppler system (Perimed AB, Järfalla, Sweden), was monitored, and body temperature was 
maintained at 37 ± 0.5 °C during surgery. To produce analgesia, buprenorphine (0.01 mg kg-
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1) was administered subcutaneously 15 min before recovery from the anaesthesia. At 24 h 
after MCA occlusion, they were deeply anesthetized with isoflurane (5%) and decapitated. 
The presence of an infarcted area, assessed by 2,3,5-triphenyltetrazolium chloride (Sigma-
Aldrich, St. Louis, MO, USA) staining, was the criteria to determine that I/R was successful 
(Pérez-Asensio et al. 2010, Onetti et al. 2015). In some experiments, non-operated rats of 
the same sex and body weight that were not subjected to surgery were used as controls. 
In a set of animals, rats were treated (i.p.) 10 min after the onset of ischemia with either the 
peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(4-sulfonatophenyl)prophyrinato iron 
(III)  (FeTPPS; 20 mg kg-1; Calbiochem, San Diego, CA, USA; Kunz et al. 2007, Coucha et 
al. 2013) or vehicle (saline). The dose used was previously shown to inhibit the peroxynitrite-
induced F-actin protein tyrosine nitration-effects on MCA myogenic function after I/R 
(Coucha et al. 2013). 
 
Middle cerebral artery preparation  
Brain was removed and placed in ice-cold Krebs-Henseleit solution (KHS - in mmol L-1: 
112.0 NaCl, 4.7 KCl, 2.5 CaCl2, 1.1 KH2PO4, 1.2 MgSO4, 25.0 NaHCO3, and 11.1 glucose) 
continuously gassed with 95% O2 and 5% CO2. Segments of MCA (wire and pressure 
myography and immunofluorescence studies) were dissected and maintained in cold KHS. 
For immunofluorescence studies, arteries were fixed with 4% phosphate-buffered 
paraformaldehyde (PFA; pH 7.4) for 1 h and washed in three changes of phosphate 
buffered-saline solution (PBS; pH 7.4). After clearing, arterial segments were placed in PBS 
containing 30% sucrose overnight, transferred to a cryomold (Bayer Química Farmacéutica, 
Barcelona, Spain) containing Tissue Tek OCT embedding medium (Sakura Finetek Europe, 
Zoeterwoude, The Netherlands), frozen in liquid nitrogen, and kept at −70 °C.  
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Wire myography  
MCA function was studied in vessels mounted on an isometric wire myograph (model 410 A; 
Danish Myo Technology, Aarhus, Denmark) following the protocol described (McNeish et al. 
2012, Gauthier et al. 2014). Constricted tone was induced with the stable TxA2 mimetic 9,11-
Dideoxy-9α,11α-methano-epoxy prostaglandin F2α (U46619; 30-100 nmol L-1; EMD 
Millipore, Billerica, MA, USA) or endothelin-1 (1-10 nmol L-1; Enzo Life Sciences Inc., 
Farmingdale, NY, USA). Contractions were maintained around 60-80% of tone obtained with 
KCl (100 mmol L-1), before adding the relaxing agonists. Endothelial-dependent relaxations 
were obtained with the agonist of proteinase-activated receptor (PAR) 2 serine–leucine–
isoleucine–glycine–arginine–leucine–NH2 (SLIGRL; 20 μmol L-1; Auspep, Tullamarine, 
Victoria, Australia), bradykinin (1 nmol L-1-30 mmol L-1; Sigma-Aldrich, St. Louis, MO, USA), 
or the potent and selective activator of small-conductance calcium-activated potassium 
(SKCa) channels N-cyclohexyl-N-2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine 
(CyPPA; 100 µmol L-1; Sigma-Aldrich, St. Louis, MO, USA; Hougaard et al. 2007). A single 
concentration of SLIGRL was used to minimize potential desensitization of PAR2 (Hwa et al. 
1996, Bucci et al. 2005). Preliminary experiments showed that it was not possible to obtain 
reliable cumulative concentration-dependent MCA relaxations to CyPPA.  
The effects of the non-selective nitric oxide synthase inhibitor Nω-nitro-l-arginine methyl 
ester (l-NAME; 300 μmol L-1; Sigma-Aldrich, St. Louis, MO, USA), the nonselective 
cyclooxygenase (COX) inhibitor indomethacin (10 μmol L-1; Sigma-Aldrich, St. Louis, MO, 
USA), the specific intermediate-conductance KCa (IKCa) channel blocker TRAM-34 (1 μmol L-
1; Sigma-Aldrich, St. Louis, MO, USA), the specific SKCa channel blocker apamin (100 nmol 
L-1; Latoxan, Valence, France), or the IKCa and large-conductance KCa (BKCa) channel 
blocker charybdotoxin (100 nmol L-1; Latoxan, Valence, France) on endothelium-dependent 
relaxation were investigated by their addition 30 min before vessel preconstriction. 
Concentrations of most inhibitors were chosen based on previous studies (McNeish & 
Garland 2007, McNeish et al. 2012, Gauthier et al. 2014). Preliminary experiments were 
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conducted to obtain the adequate concentration of the actin cytoskeleton disruptor 
cytochalasin D (50 nmol L-1; EMD Millipore, Billerica, MA, USA) that did not affect vessel 
preconstriction, and either cytochalasin D or another actin cytoskeleton disruptor latrunculin 
B (10 nmol L-1-1 μmol L-1; EMD Millipore, Billerica, MA, USA) were added 30 min before 
starting the experiment.  
The potent oxidizing and nitrating agent peroxynitrite (EMD Millipore, Billerica, MA, USA) 
was added 30 min before vessel preconstriction at a concentration of 5 µmol L-1 to affect 
vascular KCa channel activity (Liu et al. 2002). Preliminary experiments were conducted to 
obtain the adequate concentration of the oxidation/nitration inhibitor epicatechin (1 μmol L-1; 
Sigma-Aldrich, St. Louis, MO, USA) and the cytoskeleton stabilizer jasplakinolide (100 nmol 
L-1; EMD Millipore, Billerica, MA, USA) that did not affect vessel preconstriction, and were 
added 10 min before addition of peroxynitrite and maintained during peroxynitrite incubation. 
Decomposed-peroxynitrite (5 μmol L-1) was also used and added 30 min before vessel 
preconstriction. The activity of peroxynitrite and its decay after decomposition was confirmed 
by spectrophotometry according to the method described by Balavoine & Geletti (1999). 
Briefly, consumption of pyrogallol red (6 µmol L-1; Sigma-Aldrich, St. Louis, MO, USA) by 
peroxynitrite (2 µmol L-1), submitted or not to different conditions (no degradation, 4 h of light 
exposure, overnight incubation at 37 °C, overnight incubation at room temperature), was 
evaluated in the presence of diphenyl diselenide (Sigma-Aldrich, St. Louis, MO, USA), and 
absorbance was measured at 540 nm. 
 
Middle cerebral artery endothelial filamentous-actin staining  
The ipsilateral MCA from sham, I/R or non-operated (control) rats was mounted in a small 
vessel pressure myograph (model P100; Danish Myo Technology, Aarhus, Denmark) 
following the protocol previously described (Onetti et al. 2015). Arteries from control rats 
were incubated (30 min) with cytochalasin D (50 nmol L-1) or peroxynitrite (5 µmol L-1). All 
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arteries were set to 70 mmHg in 0 Ca2+-KHS, pressure-fixed with 4% PFA in 0.2 mol L-1 
phosphate buffer (pH 7.2-7.4) for 45 min, and stored overnight in PFA (4%) at 4 °C. 
Pressured-fixed intact arteries were mounted on slides in a well that was made of silicon 
spacers (to avoid artery deformation) and were double stained with the filamentous (F)-actin 
dye Alexa Fluor® 568 Phalloidin (Thermo Fisher Scientific Inc., Kalamazoo, MI, USA), 
following the manufacturer's instructions, and the nuclear dye Hoechst 33342 (0.01 mg mL-1; 
Sigma-Aldrich, St. Louis, MO, USA). Arteries were imaged with a Leica TCS SP5 (Manheim, 
Germany) confocal system at x63, at 561-nm (F-actin) and 405-nm (nuclei). Two or more 
stacks of serial optical slices (0.4-μm thick), from different regions containing at least two 
endothelial cell nuclei, were captured in each arterial segment, starting at the first emerging 
endothelial cell and proceeding into the lumen of each artery. Every image was taken under 
identical conditions of zoom (x4.5), laser intensity, brightness, and contrast. 3D image 
analysis was performed with Imaris 8.1 Image Analysis software (Bitplane, Oxford 
Instruments, Abingdon, UK). We defined two cuboid regions of interest (ROI) per stack, 
coinciding with the nuclear and cytoplasmic region of an endothelial cell, which remained 
constant for each artery. The average fluorescence intensity and volume of F-actin objects 
within each ROI was measured in the Z-axis (8-μm stack depth).  
 
Microvascular endothelial cell culture and hypoxia/reoxygenation model 
Human microvascular endothelial cell (HMVEC) lines from two different batches were 
obtained from Thermo Fisher Scientific Inc. (Kalamazoo, MI, USA), maintained in culture in 
phenol red-free DMEM-F12 supplemented with 10% (v/v) foetal bovine serum (FBS) and 
microvascular growth supplement (Thermo Fisher Scientific Inc., Kalamazoo, MI, USA), and 
incubated at 37 °C in a humidified atmosphere at 95% air and 5% CO2. Cells were plated 
onto 1% gelatine-coated culture dishes and studied before confluence between passages 5 
and 7. To induce hypoxia/reoxygenation (H/R), culture medium was changed to charcoal-
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striped low-serum (1%) media and cells were placed inside a sealed chamber. Hypoxic 
conditions were created by injection in the chamber with 94% N2, 5% CO2 and 1% O2 and 
hypoxia incubation proceeded overnight. In normoxic conditions, cells were kept overnight in 
the humidified atmosphere incubator with charcoal-striped low-serum (1%) media. Following 
hypoxia, cells were washed with PBS, fresh supplemented with DMEM-F12 + 10% FBS and 
reoxygenated in the humidified atmosphere incubator to simulate reperfusion conditions 
(Koo et al. 2001). After 24 h of reoxygenation, HMVEC were treated with U46619 (100 nmol 
L-1) for 15 min. In a series of experiments, normoxic cells were treated with peroxynitrite (500 
nmol L-1) for 2 h and processed accordingly to each experimental protocol. It was not 
possible to use the same concentration of peroxynitrite used in experiments of vascular 
function (5 µmol L-1), since this concentration considerably affected cell viability. 
 
Immunofluorescence 
The ipsilateral MCA from sham, I/R or control rats was used. Arteries from control rats were 
incubated with peroxynitrite (5 µmol L-1; 30 min; in KHS at 37 °C) before being processed for 
immunofluorescence studies. Frozen transverse sections (14-μm thick) of MCA were 
incubated (1 h) with a rabbit polyclonal antibody against SKCa channels (1:100; Alomone 
labs, Jerusalem, Israel) or nitrotyrosine (1:100; Millipore, Billerica, MA, USA). After washing, 
sections were incubated (45 min) with the secondary antibody (1:200), a donkey anti-rabbit 
IgG conjugated to Cyanine 3 (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, 
USA) at 37 °C. Sections were processed for immunofluorescence staining essentially as 
described (Onetti et al. 2015). The specificity of the immunostaining was verified by omission 
of the primary antibody and processed as above, which abolished the fluorescence signal.  
HMVEC grown on coverslips were washed with ice-cold PBS and fixed with 4% PFA. After 
permeabilization with 0.1% Triton X-100/0.1% bovine serum albumin in PBS for 5 min and 
blockage with 10% horse serum in PBS for 15 min, cells were incubated in blocking solution 
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for 1 h at room temperature with primary antibodies: SKCa channels (1:100; Alomone labs, 
Jerusalem, Israel) or nitrotyrosine (1:100; Millipore, Billerica, MA, USA). Following washes, 
cells were co-stained with fluorescence-conjugated phalloidin (10 µM; Sigma-Aldrich, St. 
Louis, MO, USA) for F-actin and deoxyribonuclease I (300 nM; Thermo Fisher Scientific Inc., 
Kalamazoo, MI, USA) for globular (G)-actin, and secondary antibodies (1:500) Alexa Fluor 
594 conjugated goat anti-rabbit for SKCa channels and Alexa Fluor 488 conjugated goat anti-
rabbit (Thermo Fisher Scientific Inc., Kalamazoo, MI, USA) for nitrotyrosine. Coverslips were 
mounted on slides using ProLong Gold antifade reagent with DAPI (Thermo Fisher Scientific 
Inc., Kalamazoo, MI, USA), and visualized through a confocal microscope (Axiovert 2000, 
Carl Zeiss Iberia, S.L., Spain) with a x63 objective lens (Carl Zeiss Iberia, S.L., Spain). 
Images were taken from 15-20 cells per coverslip. 
 
Western blotting 
Equal amount of protein from each cell sample (25 µg) was resolved by SDS-PAGE on 4-
12% gels and electroblotted onto nitrocellulose. Membranes were incubated overnight at 4 
°C in PBS with 0.1% (v/v) Tween 20 (PBST) containing 2% milk and specified polyclonal 
rabbit primary antibodies (1:500) as follows: anti-SKCa channels (Alomone labs, Jerusalem, 
Israel); anti-nitrotyrosine (Millipore, Billerica, MA, USA); or anti HIF-1α (Millipore, Billerica, 
MA, USA). After incubation with horseradish peroxidase-labelled specific secondary 
antibodies in PBST containing 1% milk and additional washes, chemiluminescent signal was 
visualized by LAS4000 imaging system (Fujifilm, Barcelona, Spain). Densitometric analyses 
of Western blots were performed using a Mac Biophotonic ImageJ Software. All membranes 
were reblotted using a monoclonal antibody anti GAPDH (1:2500; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) as a loading control. Data were normalized to 
corresponding values of GAPDH densitometry.  
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Endothelial cell filamentous/globular-actin measurements 
Cells were grown on 60 mm dishes and went through H/R and treatment processes as 
described above. Subsequently, cells were washed once in ice-cold PBS before lysis with 
actin stabilization buffer (Cytoskeleton, Denver, CO, USA) on ice for 10 min. Cells were 
dislodged by scraping and the entire extract was incubated at 37 °C for 10 min. Samples 
were ultra-centrifuged (100,000 g) for 1 h at 37 °C. The supernatant containing globular (G)-
actin was recovered, and the pellet containing F-actin was solubilized with actin 
depolymerisation buffer (Cytoskeleton, Denver, CO, USA). Aliquots of supernatant and pellet 
fractions were separated on 4-12% SDS-PAGE gels and then immunoblotted with 
monoclonal anti-actin antibody (Cytoskeleton, Denver, CO, USA). Chemiluminescent signal 
was detected by chemiluminescent reagent according to the manufacturer's protocols 
(SuperSignal west pico, Thermo Fisher Scientific Inc., Kalamazoo, MI, USA), and visualized 
by LAS4000 imaging system (Fujifilm, Barcelona, Spain).  
 
RhoA activation pull-down assay 
Cells were grown on 60 mm dishes. After H/R and treatment processes described above, 
cells were cross-linked with Coupling Buffer (0.01 mol L-1 sodium phosphate, 0.15 mol L-1 
NaCl; 20 µg mL-1 disuccinimidyl suberate; pH 7.2). Cells were washed twice in PBS, 
incubated for 10 min in Mg++ lysis buffer (MLB; 25 mmol L-1 HEPES, pH 7.5, 150 mmol L-1 
NaCl, 1% Igepal CA-630, 10 mmol L-1 MgCl2, 1 mmol L-1 EDTA and 2% glycerol). Cell 
lysates were harvested by scraping and nuclei were collected by centrifugation (5 min, 
14,000 g, 4 °C). Equal amount of protein (50 µg) was incubated overnight at 4 °C with 
Rhotekin RBD agarose (Millipore, Billerica, MA, USA) containing 65 µg of recombinant Rho 
binding domain protein in 50 µL of glutathione-agarose slurry. After 3 washes with MLB and 
proper elution by boiling in Laemmli reducing buffer, samples were separated on 4-12% 
SDS-PAGE gels and then immunoblotted with monoclonal anti-RhoA antibody (1:1000; 
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Santa Cruz Biotechnologies, Santa Cruz, CA, USA). Cell extracts from a serum-starved 
state (low basal RhoA activity) were used as negative control. Positive controls were aliquots 
treated with 100 µmol L-1 of GTPγS non-hydrolyzable analog to activate RhoA. Pull-down 
signal was normalized by total RhoA signal in aliquots of cell lysates not loaded with 
Rhotekin RBD agarose.  
 
Statistical analysis 
Results are expressed as mean ± SEM of the number (n) of arteries from different animals 
or independent cell culture experiments indicated in the figure legends. Vasodilator 
responses were expressed as the percentage change of the previous tone calculated by 
subtracting resting tone from U46619 or endothelin-1 contraction. A two-way ANOVA 
followed by Tukey's post-test was used, when appropriate. In the case of one single factor, 
unpaired Student's t-test or one-way ANOVA followed by Tukey's post-test was used for two 
or more than two groups, respectively. Data analysis was carried out using GraphPad Prism 
version 4 software. A value of P < 0.05 was considered significant. 
 
Results 
Influence of U46619 stimulation on EDH-type MCA relaxation after I/R 
Endothelium-dependent relaxation to SLIGRL (20 μmol L-1) following preconstriction with 
U46619 (30-100 nmol L-1) was impaired in MCA from the ischemic ipsilateral (103.50 ± 
3.64%; n = 15) compared to the non-ischemic contralateral hemisphere (124.62 ± 4.64%; P 
< 0.05; n = 12) or sham (128.76 ± 4.45%; P < 0.01; n = 24) vessels. However, when arteries 
were treated with l-NAME (300 μmol L-1) plus indomethacin (10 μmol L-1), SLIGRL evoked 
larger EDH-type relaxation in U46619-preconstricted ipsilateral (P < 0.01), but not 
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contralateral, MCA compared to sham (Fig. 1a). All further experiments of arterial function 
involving I/R animals were performed in ipsilateral MCA. Bradykinin evoked concentration-
dependent EDH-type relaxation in vessels preconstricted with U46619 that was similar 
between I/R and sham arteries (Figure S1). When MCA were preconstricted with endothelin-
1 (1-10 nmol L-1), relaxations to SLIGRL were equally small in MCA from I/R (22.54 ± 9.55%; 
n = 5) and sham (34.29 ± 7.33%; n = 4) rats.  
 
Effect of KCa channel blockers on EDH-type MCA relaxation after I/R 
The specific IKCa channel blocker TRAM-34 (1 μmol L-1) reduced SLIGRL relaxation in 
U46619-preconstricted MCA from both I/R and sham animals (Fig. 1b, c). However, the 
degree of EDH-type relaxation was still greater (P < 0.05) in I/R than sham arteries. The 
specific SKCa channel blocker apamin (100 nmol L-1) diminished (P < 0.001) EDH-type 
relaxations in I/R, but not sham arteries. Addition of TRAM-34 plus apamin similarly reduced 
EDH-type relaxation in I/R and sham arteries. Comparing incubation of TRAM-34 alone with 
TRAM-34 plus apamin, EDH-type relaxation only decreased (P < 0.01) in the I/R group (Fig. 
1b, c). In all groups, EDH-type responses were abolished in the presence of a combination 
of apamin with the IKCa and BKCa channel blocker charybdotoxin (100 nmol L-1; results not 
shown).  
 
Rho-mediated signal activation in HMVEC submitted to H/R  
Although H/R in isolated cells does not recapitulate all aspects of I/R injury, it provides an 
interesting model for studying the molecular mechanisms involved in the increased EDH-
type relaxation in MCA after I/R. We submitted HMVEC to H/R, a cell culture model of I/R 
(Koo et al. 2001). As observed in Figure 2a and S2, expression of hypoxia-inducible factor 
1 (HIF-1) was higher in cells that have undergone H/R than in those kept in normoxia. 
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These results suggest that our cell system is a suitable model for H/R in endothelial cells. 
Rho activation is an important regulator of the activity of some ion channels (Ghisdal et al. 
2003, Luykenaar et al. 2009), which may play a role on TP-dependent inhibition of SKCa 
channel function in the endothelium (McNeish et al. 2012, Gauthier et al. 2014). We 
analysed GTP-bound RhoA levels as a measure of RhoA activation (Fig. 2b), and found that 
15-min treatment with U46619 increased RhoA activity in both control (P < 0.05) and H/R (P 
< 0.001) conditions. It is important to note that H/R per se did not modify RhoA activity, but 
markedly augmented (P < 0.01) RhoA activation following U46619 stimulation. These results 
suggest an exaggerated TP-mediated RhoA activation after H/R in comparison to control 
conditions.  
 
SKCa channel expression   
To determine if I/R-induced increase in SKCa channel signalling is related to changes in 
SKCa channel levels, we measured SKCa channel protein expression in both HMVEC and 
rat MCA (Fig. 3). We observed that neither U46619 stimulation nor exposure to H/R 
altered SKCa channel protein levels in HMVEC, as assessed by Western blotting (Fig. 3a 
and S3). We also studied protein levels, assessed by immunofluorescence, of SKCa 
channels in HMVEC (Fig. 3b) and MCA cross sections from sham and I/R rats (Fig. 3c). 
SKCa channel fluorescence was similar in control and H/R HMVEC (Fig. 3b). Positive red 
immunofluorescence signal for SKCa channels was restricted to the adventitia and 
endothelial layers of the MCA, and was similar in sham and I/R arteries (Fig. 3c).  
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Actin content and distribution  
The content and distribution of F- and G-actin in HMVEC is shown in Figure 4. Exposure of 
endothelial cells to H/R led to a decrease in F-actin fluorescence (Fig. 4a) that was 
paralleled by a marked decrease (P < 0.001) in the amount of F-actin (Fig. 4b), while G-actin 
expression remained unaffected (Fig. 4a, b). No appreciable differences on F- and G-actin 
were observed after U46619 incubation when compared to its own control (Fig. 4a, b). 
Similar to H/R, exogenous peroxynitrite (500 nmol L-1) was able to reduce both the F-actin 
fluorescence (Fig. 4a) and the F/G actin ratio (Fig. 4b) in HMVEC. In intact and pressurized 
MCA, endothelial F-actin object volume, but not fluorescence, was decreased (P < 0.05) in 
I/R versus sham arteries (Fig. 4c). Similarly, incubation of MCA from non-operated (control) 
rats with cytochalasin D (50 nmol L-1) or peroxynitrite (5 μmol L-1) was without effect on F-
actin fluorescence, but significantly diminished (P < 0.05) F-actin object volume (Fig. 4c).   
 
Effect of actin cytoskeleton disruption on EDH-type relaxation of control MCA 
The role of actin organization on EDH-type vasodilation following TP stimulation was 
evaluated by using different agents that disrupt actin cytoskeleton at doses that did not affect 
U46619-preconstriction. We first studied the effect of different concentrations of the actin 
filament assembly inhibitor latrunculin B (Spector et al. 1989) on EDH-type responses in 
MCA from non-operated (control) rats, as these arteries showed a similar EDH-type 
response following TP stimulation than sham arteries (Fig. 5). Latrunculin B did not modify 
the basal tone (Table S1), and induced a progressive decrease of EDH-type relaxation in 
control arteries (Fig. 5a). We next tested the effect of cytochalasin D, an actin cytoskeleton-
disrupting agent that acts by a different mechanism than latrunculin B. Cytochalasin D 
induces barbed end capping and, at higher doses, severing of actin filaments, which 
progressively depolymerize actin polymers (Wakatsuki et al. 2001). In contrast to latrunculin 
B, exposure of control arteries to cytochalasin D (50 nmol L-1) did potentiate (P < 0.01) EDH-
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
type relaxation (Fig. 5b), without altering the basal tone (Table S1). The cytochalasin D-
induced potentiation of the EDH-type response was significantly diminished by incubation of 
apamin and TRAM-34, alone or in combination (Fig. 5b). To confirm the presence of SKCa 
channel input to EDH, we selectively activated SKCa channels with CyPPA (100 μmol L-1; 
Hougaard et al. 2007), which induced a higher (P < 0.01) relaxation in cytochalasin D-
incubated than control arteries (Fig. 5c). Lastly, addition of apamin significantly reduced (P < 
0.001) CyPPA relaxation in cytochalasin D, but not in control (P = 0.220), arteries.  
 
Detection of protein tyrosine nitration  
Immunofluorescent and Western blot analysis of protein tyrosine nitration showed an 
increase (P < 0.001) in nitrotyrosine fluorescence/expression in HMVEC exposed to H/R 
(Fig. 6a, b and S4), comparable to levels seen when cells were treated with peroxynitrite 
(500 nmol L-1; Fig. 6b). In MCA cross sections, a weak nitrotyrosine fluorescent signal was 
found in sham arteries, whereas after I/R, marked protein tyrosine nitration was observed in 
all three layers of the vessel wall, including the endothelial layer (Fig. 6c). Similar to I/R, 
exogenous incubation of control MCA with peroxynitrite (5 μmol L-1) also promoted marked 
protein tyrosine nitration of the vessel wall, including the endothelial layer. 
 
Impact of exogenous peroxynitrite on EDH-type relaxation of control MCA 
Subsequent experiments examined the effect of peroxynitrite (5 μmol L-1) exposure on EDH-
type relaxation after U46619 preconstriction in arteries from control rats (Fig. 7a, b). 
Incubation of MCA with peroxynitrite did not modify the basal tone (Table S1), but increased 
(P < 0.01) the SLIGRL-evoked EDH-type relaxation (Fig. 7a). Inhibition of protein 
oxidation/nitration with epicatechin (1 μmol L-1) or induction of F-actin stabilization with 
jasplakinolide (100 nmol L-1) was not associated with increased EDH-type relaxation by 
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peroxynitrite. In addition, exposure of control arteries to decomposed-peroxynitrite (5 μmol L-
1), obtained by submitting peroxynitrite to overnight incubation at 37 °C (Figure S5), was 
unable to potentiate EDH-type responses (Fig. 7a). Peroxynitrite-induced potentiation of the 
EDH-type response was significantly diminished by incubation of apamin and TRAM-34, 
alone or in combination (Fig. 7b). In addition, EDH-type relaxation decreased (P < 0.05) 
when comparing incubation of TRAM-34 alone with TRAM-34 plus apamin. Furthermore, 
CyPPA relaxation augmented (P < 0.01) after peroxynitrite, but not decomposed-
peroxynitrite, exposure (Fig. 7c).  
 
Effect of catalytically decomposing endogenous peroxynitrite on EDH-type 
MCA relaxation after I/R 
To determine the in vivo effect of peroxynitrite formed during I/R on EDH-type relaxation 
following TP stimulation in MCA, rats were treated with FeTPPS (20 mg kg-1), a selective 
peroxynitrite decomposition catalyst (Kunz et al. 2007, Coucha et al. 2013), or saline 
(vehicle; Fig. 7d, e). Body weight, body temperature and percentage changes in cortical CBF 
during surgery are shown in Table S2. I/R rats treated with vehicle showed a larger (P < 
0.01) EDH-type relaxation than vehicle-treated sham or FeTPPS-treated I/R rats (Fig. 7d). 
Addition of TRAM-34 alone or TRAM-34 plus apamin reduced EDH-type relaxation in any 
group compared to non-treated arteries. Remarkably, comparing incubation of TRAM-34 
alone with TRAM-34 plus apamin, EDH-type relaxation only significantly decreased (P < 
0.001) in I/R rats treated with vehicle, suggesting the presence of SKCa channel input to EDH 
(Fig. 7d). Consistent with this, CyPPA-mediated relaxation was larger (P < 0.01) in MCA 
from vehicle-treated I/R than sham rats, and this effect was prevented by apamin incubation 
or in vivo FeTPPS treatment (Fig. 7e). 
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Discussion 
Results from the present study show that PAR2-evoked EDH-type relaxation is greater in 
U46619-preconstricted MCA of I/R compared to sham rats. We demonstrate that the 
increased EDH-type relaxation of the MCA after I/R is due to the inability of TP stimulation to 
block the SKCa channel EDH. We propose that the underlying mechanism involves increased 
peroxynitrite production and endothelial cell F-actin disruption during I/R.  
An increase in EDH-type MCA relaxation of the basal tone to uridine 5’-triphosphate has 
been reported after cerebral I/R (Marrelli et al. 1999, Marrelli 2002). In the present study, I/R 
only potentiated EDH-type responses to SLIGRL in U46619-preconstricted arteries, 
suggesting the involvement of specific receptor activation. Similarly, PAR2 signalling is 
unaltered with stroke in the MCA of stroke-prone spontaneously hypertensive rats (Smeda & 
McGuire 2007). Previous evidence suggests that increases in EDH-type MCA relaxation 
after cerebral I/R could be triggered by a mechanism involving KCa channels (Marrelli et al. 
1999). These observations were followed by studies demonstrating that KCa channels 
mediate the EDH response in rat MCA (McNeish et al. 2005, McNeish et al. 2006). Thus, it is 
plausible that augmented EDH-type relaxation following I/R is achieved through an increase 
of KCa channel signalling. We demonstrate SKCa channels are expressed in the endothelial 
layer of rat MCA, consistent with previous observations (McNeish et al. 2006), and that SKCa 
channels are also detected within the adventitia. Interestingly, SKCa channel expression was 
unaltered after I/R, as reported in parenchymal arterioles branching from the MCA (Cipolla et 
al. 2009). 
When the MCA is able to synthesize NO, both IKCa and SKCa channels contribute to EDH 
responses. However, under NO-deprived (McNeish et al. 2006) or TP-stimulated (McNeish & 
Garland 2007) conditions, the SKCa channel component of EDH is blocked. SKCa channel 
activity can be restored by exposure to COX inhibitors or TP antagonists (McNeish & 
Garland 2007; McNeish et al. 2012, Gauthier et al. 2014), demonstrating a role for TP 
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stimulation in suppressing SKCa channel function (Plane & Garland 1996, Crane & Garland 
2004, McNeish & Garland 2007). Indeed, U46619-preconstricted MCA from sham rats had 
no SKCa channel component to EDH-type relaxation. Surprisingly, we found that the SKCa 
channel input to EDH-type responses was restored after I/R, increasing EDH-type relaxation 
compared to sham arteries. Whilst following I/R there was still an IKCa channel component to 
EDH-type relaxation, SKCa appeared to be the dominant channel as apamin virtually 
abolished relaxation and the residual relaxations were not inhibited to a greater extent by 
additional blockade of IKCa channels. In addition, direct stimulation of SKCa channels with the 
selective SKCa channel activator CyPPA (Hougaard et al. 2007) induced a greater relaxation 
in I/R than sham arteries. Together, these findings suggest that I/R has direct effects on 
SKCa channel activity independent of other components of the EDH response, and thus we 
focussed on the effect of I/R on this channel throughout the rest of the study.  
Activity of ion channels in numerous tissues is regulated by the actin cytoskeleton and 
cytoskeletal elements are responsible for localization and clustering of channel molecules in 
the plasma membrane (Levina et al. 1994). We found that H/R causes disruption of actin 
filaments in isolated endothelial cells. In parallel, cytochalasin D-induced depolymerisation of 
actin polymers (Spector et al. 1989, Wakatsuki et al. 2001), but not latrunculin B-induced 
prevention of actin monomer polymerization (Spector et al. 1989), augments the SKCa 
channel input to EDH-type relaxation in the MCA. Furthermore, cytochalasin D also 
increased direct SKCa channel relaxation evoked by CyPPA. Together, these results suggest 
the presence of an intact endothelial cell actin cytoskeletal preformed network is essential to 
TP-dependent inhibition of SKCa channel-mediated relaxation. Similarly, an intact actin 
cytoskeleton is necessary for Rho kinase inhibition of smooth muscle cell delayed-rectifier 
potassium channel activity, thus facilitating cerebral artery depolarization and constriction 
(Luykenaar et al. 2009). As TP-dependent inhibition of SKCa channel function has also been 
associated with Rho kinase activation in rat MCA (McNeish et al. 2012), we investigated if 
such regulation could be related to the effect of Rho kinase on reorganization of the 
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endothelial cell actin cytoskeleton (Gorovoy et al. 2005, Luykenaar et al. 2009, Prasain & 
Stevens 2009). We found greater activation of Rho kinase after U46619 stimuli in endothelial 
cells that underwent H/R than those under normoxic conditions, although it was not able to 
restore the actin disruption observed. Clearly, more detailed examination is required to 
determine the mechanism by which endothelial cell actin cytoskeleton influences SKCa 
channel activity. However, correct SKCa channel anchoring to cytoskeleton-binding proteins 
is essential for channel trafficking and activity (Lu et al. 2009, Rafizadeh et al. 2014).   
I/R is often associated with increased generation of reactive oxygen and nitrogen species, 
which react rapidly to form peroxynitrite (Yasmin et al. 1997). Peroxynitrite is known to 
contribute to the brain ischemic tolerance and protection afforded by lipopolysaccharide 
preconditioning (Kunz et al. 2007). In addition, peroxynitrite directly affects BKCa activity 
(Brzezinska et al. 2000, Liu et al. 2002, Li et al. 2005) and alters function of other proteins by 
causing both oxidation and posttranslational nitration of tyrosine residues (Palomares & 
Cipolla 2011). Actin is a tyrosine-rich protein and cerebral artery smooth muscle F-actin 
nitration is observed in conditions of increased peroxynitrite production, such as I/R, leading 
to myogenic tone impairment in cerebral arteries (Maneen et al. 2006, Maneen & Cipolla 
2007, Coucha et al. 2013). In the present study, we observed increased protein tyrosine 
nitration and decreased F/G-actin ratio in HMVEC exposed to peroxynitrite that was similar 
to cells submitted to H/R. Furthermore, in rat MCA, endothelial protein tyrosine nitration was 
coupled to F-actin fragmentation either after I/R or peroxynitrite exposure. Incubation of 
control arteries with peroxynitrite also prevented the U46619-induced block of SKCa 
component of EDH-type relaxation and even potentiated these responses, which were 
similar to those observed after I/R. It is unlikely that other substances derived from the 
peroxynitrite molecule could be responsible for these effects, as decomposed peroxynitrite 
did not modify EDH-type relaxation. We then assessed if peroxynitrite generated during I/R 
was involved in augmenting MCA SKCa-mediated relaxation. Rats were treated with 
FeTPPS, a selective peroxynitrite decomposition catalyst (Coucha et al. 2013, Kunz et al. 
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2007), early after occlusion onset to avoid peroxynitrite effects before treatment. The MCA 
from rats submitted to I/R and treated with FeTPPS showed the U46619-induced block of 
SKCa channel relaxation, resulting in similar EDH-type responses to the sham-vehicle group. 
Together, these findings suggest that peroxynitrite formed during I/R helps prevent loss of 
EDH-type relaxation following TP stimulation in the MCA, through a mechanism that involves 
the preservation of SKCa channel activity.  
It is not clear at this stage if peroxynitrite-induced disruption of endothelial F-actin is the only 
contributor to augmented EDH-type responses. Indeed, other oxidative stress-derived 
molecules produced during I/R such as superoxide anion and hydrogen peroxide may 
potentially disrupt the actin cytoskeleton (Moldovan et al. 1999, Dalle-Donne et al. 2001, 
Boardman et al. 2004). Besides, several studies suggest that oxidative stress can potentiate 
Ca2+ release from endothelial stores (Edwards et al. 2008, Lock et al. 2012) and enhance 
endothelial KCa channel-induced relaxation (Edwards et al. 2008). Interestingly, I/R is 
associated with augmented endothelial Ca2+ responses in the rat MCA leading to increased 
EDH-type dilations to uridine 5’-triphosphate (Marrelli 2002). Therefore, further studies are 
required to determine whether peroxynitrite or other oxidative stress-derived molecules 
produced during I/R are also capable of augmenting endothelial SKCa channel relaxations by 
potentiating Ca2+ release from endothelial stores. Finally, the present study has a few 
technical limitations that deserve attention. First, the changes observed in an isolated human 
microvascular endothelial cell line do not necessarily reflect those of the endothelial layer of 
a rat MCA, as, for instance, the vessel source and the isolation and culture of cells affect cell 
phenotype and function; and second, in our Western blot analysis of SKCa channel 
expression, we were unable to detect the functional high molecular weight form of the 
channel, and additionally, we could not discard that SKCa channel structure/expression may 
differ in cultured HMVEC and intact rat MCA; and third, although we have used one of the 
rodent models that most closely resembles a human ischemic stroke, the disadvantages of 
the use of an animal stroke model should be considered (Fluri et al. 2015).  
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Cerebral artery constriction can worsen brain damage during I/R, whereas dilation can 
decrease cerebrovascular resistance and contribute to blood-brain barrier disruption and 
oedema formation (Palomares & Cipolla 2011). For example, reactive hyperaemia (i.e. CBF 
increases above basal levels at reperfusion) has been associated with adverse events such 
as increased blood-brain barrier leakage, oedema and more severe brain damage in 
experimental (Pérez-Asensio et al. 2010, Onetti et al. 2015) and human (Yu et al. 2015) 
ischaemic stroke. Notably, reactive hyperaemia is coupled to exacerbated protein tyrosine 
nitration in brain parenchyma and MCA (Pérez-Asensio et al. 2010, Onetti et al. 2015). 
Similarly, the greater EDH-type relaxation induced by peroxynitrite under prothrombotic 
conditions may contribute to decrease cerebrovascular resistance, promoting further brain 
damage during I/R.  
In summary, we have demonstrated that the ability of TP stimulation to curtail EDH-type 
relaxation evoked by PAR2 signalling is absent after I/R, which reveal a novel mechanism 
whereby EDH may compensate loss of NO-mediated relaxation in prothrombotic disease 
states such as ischaemic stroke (Chamorro 2009). While this response could be considered 
as a key mechanism to improve regional blood flow (Golding et al. 2002), it might also 
contribute to blood-brain barrier disruption and oedema formation. We therefore propose that 
peroxynitrite-induced augmented EDH-type responses may constitute a previously 
unidentified mechanism involved in promoting neurovascular injury during I/R. The present 
experimental study support the use of peroxynitrite decomposing/scavenging compounds as 
potentially effective therapeutic strategies in the treatment of postischemic brain injury.  
 
Conflict of interest 
The authors have no conflict of interests. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Acknowledgments 
We are grateful to Prof. Gustavo Egea for helpful comments and to the confocal microscopy 
core from the Institut de Neurociències (Universitat Autònoma de Barcelona). This work was 
supported by Ministerio de Ciencia e Innovación [SAF2010-19282, SAF2014-56111-R] to 
E.V.; Generalitat de Catalunya [2014SGR574] to E.V. and F.J-A.; and Instituto de Salud 
Carlos III [FIS PI13/0091, RIC RD12/0042/0006] to AP.D. Y.O. is a predoctoral fellow of the 
Ministerio de Educación y Ciencia (Spain). 
 
References  
Balavoine, G.G. & Geletii, Y.V. 1999. Peroxynitrite scavenging by different antioxidants. Part 
I: convenient assay. Nitric Oxide 3, 40–54. 
Boardman, K.C., Aryal, A.M., Miller, W.M. & Waters, C.M. 2004. Actin re-distribution in 
response to hydrogen peroxide in airway epithelial cells. J Cell Physiol 199, 57–66. 
Brzezinska, A.K., Gebremedhin, D., Chilian, W.M., Kalyanaraman, B. & Elliott, S.J. 2000. 
Peroxynitrite reversibly inhibits Ca(2+)-activated K(+) channels in rat cerebral artery smooth 
muscle cells. Am J Physiol Heart Circ Physiol  278, 1883–1890. 
Chamorro, A. 2009. TP receptor antagonism: a new concept in atherothrombosis and stroke 
prevention. Cerebrovasc Dis 27, 20–27. 
Cipolla, M.J. 2009. The Cerebral Circulation. In: Colloquium Series on Integrated Systems 
Physiology: From Molecule to Function, pp. 1-59. Morgan & Claypool Life Sciences, San 
Rafael (CA).  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Cipolla, M.J., Smith, J., Kohlmeyer, M.M. & Godfrey, J.A. 2009. SKCa and IKCa Channels, 
myogenic tone, and vasodilator responses in middle cerebral arteries and parenchymal 
arterioles: effect of ischemia and reperfusion. Stroke 40, 1451–1457. 
Coucha, M., Li, W., Johnson, M.H., Fagan, S.C., Ergul, A. 2013. Protein nitration impairs the 
myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres 
after ischemic stroke. Am J Physiol Heart Circ Physiol  305, 1726–1735. 
Coutts, S.B. & Goyal, M. 2009. When recanalization does not improve clinical outcomes. 
Stroke 40, 2661. 
Crane, G.J. & Garland, C.J. 2004. Thromboxane receptor stimulation associated with loss of 
SKCa activity and reduced EDHF responses in the rat isolated mesenteric artery. Br J 
Pharmacol 142, 43–50.  
Dalle-Donne, I., Rossi, R., Milzani, A., Di Simplicio, P. & Colombo, R. 2001. The actin 
cytoskeleton response to oxidants: from small heat shock protein phosphorylation to 
changes in the redox state of actin itself. Free Radic Biol Med 31, 1624–1632. 
Edwards, D.H., Li, Y. & Griffith, T.M. 2008. Hydrogen peroxide potentiates the EDHF 
phenomenon by promoting endothelial Ca2+ mobilization. Arterioscler Thromb Vasc Biol 
28,1774–1781. 
Ellinsworth, D.C., Shukla, N., Fleming, I. & Jeremy, J.Y. 2014. Interactions between 
thromboxane A₂, thromboxane/prostaglandin (TP) receptors, and endothelium-derived 
hyperpolarization. Cardiovasc Res 102, 9–16. 
Fluri, F., Schuhmann, M.K. & Kleinschnitz, C. 2015. Animal models of ischemic stroke and 
their application in clinical research. Drug Des Devel Ther 9, 3445–3454. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Gauthier, K.M., Campbell, W.B. & McNeish, A.J. 2014. Regulation of KCa2.3 and 
endothelium-dependent hyperpolarization (EDH) in the rat middle cerebral artery: the role of 
lipoxygenase metabolites and isoprostanes. PeerJ 2, e414.  
George, P.M. & Steinberg G.K. 2015. Novel Stroke Therapeutics: Unraveling Stroke 
Pathophysiology and Its Impact on Clinical Treatments. Neuron 87, 297–309. 
Ghisdal, P., Vandenberg, G. & Morel, N. 2003. Rho-dependent kinase is involved in agonist-
activated calcium entry in rat arteries. J Physiol 551, 855–867. 
Golding, E.M., Marrelli, S.P., You, J. & Bryan, R.M. Jr. 2002. Endothelium-derived 
hyperpolarizing factor in the brain: a new regulator of cerebral blood flow? Stroke 33, 661–
663. 
Gorovoy, M., Niu, J., Bernard, O., Profirovic, J., Minhall, R., Neamu, R. & Voyno-
Yasenetskaya, T. 2005. LIM kinase 1 coordinates microtubule stability and actin 
polymerization in human endothelial cells. J Biol Chem 280, 26533–26542.  
Hougaard, C., Eriksen, B.L., Jørgensen, S., Johansen, T.H., Dyhring, T., Madsen, L.S., 
Strøbaek, D. & Christophersen, P. 2007. Selective positive modulation of the SK3 and SK2 
subtypes of small conductance Ca2+-activated K+ channels. Br J Pharmacol 151, 655–665. 
Hwa, J.J., Ghibaudi, L., Williams, P., Chintala, M., Zhang, R., Chatterjee, M. & Sybertz, E. 
1996. Evidence for the presence of a proteinase-activated receptor distinct from the 
thrombin receptor in vascular endothelial cells. Circ Res 78, 581–588. 
Kilkenny, C., Browne, W.J. & Cuthill, I.C., Emerson, M. & Altman, D.G. 2010. Improving 
Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. 
PLOS Biol 8, e1000412. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Kojo, K.H., Higaki, T., Kutsuna, N., Yoshida, Y., Yasuhara, H. & Hasezawa, S. 2013. Roles 
of cortical actin microfilament patterning in division plane orientation in plants. Plant Cell 
Physiol 54, 1491–1503.  
Koo, D.D., Welsh, K.I., West, N.E., Channon, K.M., Penington, A.J., Roake, J.A., Morris, P.J. 
& Fuggle, S.V. 2001. Endothelial cell protection against ischemia/reperfusion injury by 
lecithinized superoxide dismutase. Kidney Int 60, 786–796. 
Koumura, A., Hamanaka, J., Kawasaki, K., Tsuruma, K., Shimazawa, M., Hozumi, I., 
Inuzuka, T. & Hara, H. 2011. Fasudil and ozagrel in combination show neuroprotective 
effects on cerebral infarction after murine middle cerebral artery occlusion. J Pharmacol Exp 
Ther 338, 337–344. 
Kunz, A., Park, L., Abe, T., Gallo, E.F., Anrather, J., Zhou, P. & Iadecola, C. 2007. 
Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen 
species. J Neurosci 27, 7083–7093. 
Levina, N.N., Lew, R.R. & Heath, I.B. 1994. Cytoskeletal regulation of ion channel 
distribution in the tip-growing organism Saprolegnia ferax. J Cell Sci 107, 127–134.  
Li, J., Li, W., Altura, B.T. & Altura, B.M. 2005. Peroxynitrite-induced relaxation in isolated rat 
aortic rings and mechanisms of action. Toxicol Appl Pharmacol 209, 269–276. 
Liu, Y., Terata, K., Chai, Q., Li, H., Kleinman, L.H. & Gutterman, D.D. 2002. Peroxynitrite 
inhibits Ca2+-activated K+ channel activity in smooth muscle of human coronary arterioles. 
Circ Res 91, 1070–1076. 
Lock, J.T., Sinkins, W.G. & Schilling, W.P. 2012. Protein S-glutathionylation enhances Ca2+-
induced Ca2+ release via the IP3 receptor in cultured aortic endothelial cells. J Physiol 590, 
3431–3447.  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Lu, L., Timofeyev, V., Li, N., Rafizadeh, S., Singapuri, A., Harris, T.R. & Chiamvimonvat, N. 
2009. Alpha-actinin2 cytoskeletal protein is required for the functional membrane localization 
of a Ca2+-activated K+ channel (SK2 channel). Proc Natl Acad Sci U S A 106, 18402–
18407. 
Luykenaar, K.D., El-Rahman, R.A., Walsh, M.P. & Welsh, D.G. 2009. Rho-kinase-mediated 
suppression of KDR current in cerebral arteries requires an intact actin cytoskeleton. Am J 
Physiol Heart Circ Physiol 296, 917–926. 
Maneen, M.J. & Cipolla, M.J. 2007. Peroxynitrite diminishes myogenic tone in cerebral 
arteries: role of nitrotyrosine and F-actin. Am J Physiol Heart Circ Physiol 292, 1042–1050.  
Maneen, M.J., Hannah, R., Vitullo, L., DeLance, N. & Cipolla, M.J. 2006. Peroxynitrite 
diminishes myogenic activity and is associated with decreased vascular smooth muscle F-
actin in rat posterior cerebral arteries. Stroke 37, 894–899.  
Marrelli, S.P. 2002. Altered endothelial Ca2+ regulation after ischemia/reperfusion produces 
potentiated endothelium-derived hyperpolarizing factor-mediated dilations. Stroke 33, 2285–
2291. 
Marrelli, S.P., Khorovets, A., Johnson, T.D., Childres, W.F. & Bryan, R.M. Jr. 1999. P2 
purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion. 
Am J Physiol 276, 33–41. 
McNeish, A.J., Dora, K.A., & Garland, C.J. 2005. Possible role for K+ in endothelium-derived 
hyperpolarizing factor-linked dilatation in rat middle cerebral artery. Stroke 36, 1526–1532.  
McNeish, A.J. & Garland, C.J. 2007. Thromboxane A2 inhibition of SKCa after NO synthase 
block in rat middle cerebral artery. Br J Pharmacol 151, 441–449.  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
McNeish, A.J., Jimenez-Altayo, F., Cottrell, G.S. & Garland, C.J. 2012. Statins and selective 
inhibition of Rho kinase protect small conductance calcium-activated potassium channel 
function (K(Ca)2.3) in cerebral arteries. PLoS One 7, e46735. 
McNeish, A.J., Sandow, S.L., Neylon, C.B., Chen, M.X., Dora, K.A., & Garland, C.J. 2006. 
Evidence for involvement of both IKCa and SKCa channels in hyperpolarizing responses of 
the rat middle cerebral artery. Stroke 37, 1277–1282. 
Moldovan, L., Irani, K., Moldovan, N.I., Finkel, T. & Goldschmidt-Clermont, P.J. 1999. The 
actin cytoskeleton reorganization induced by Rac1 requires the production of superoxide. 
Antioxid Redox Signal 1, 29–43. 
Onetti, Y., Dantas, A.P., Pérez, B., Cugota, R., Chamorro, A., Planas, A.M., Vila, E. & 
Jiménez-Altayó, F. 2015. Middle cerebral artery remodeling following transient brain 
ischemia is linked to early postischemic hyperemia: a target of uric acid treatment. Am J 
Physiol Heart Circ Physiol 308, 862–874. 
Palomares, S.M. & Cipolla, M.J. 2011. Vascular protection following ischemia and 
reperfusion. J Neurol Neurophysiol 20, S1–004. 
Pérez-Asensio, F.J., de la Rosa, X., Jiménez-Altayó, F., Gorina, R., Martínez, E., 
Messeguer, A., Vila, E., Chamorro, A. & Planas, A.M. 2010. Antioxidant CR-6 protects 
against reperfusion injury after a transient episode of focal brain ischemia in rats. J Cereb 
Blood Flow Metab 30, 638–652. 
Plane, F. & Garland, C.J. 1996. Influence of contractile agonists on the mechanism of 
endothelium-dependent relaxation in rat isolated mesenteric artery. Br J Pharmacol 119, 
191–193. 
Prasain, N. & Stevens, T. 2009. The actin cytoskeleton in endothelial cell phenotypes. 
Microvasc Res 77, 53–63.  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Rafizadeh, S., Zhang, Z., Woltz, R.L., Kim, H.J., Myers, R.E., Lu, L., Tuteja, D., Singapuri, 
A., Bigdeli, A.A., Harchache, S.B., Knowlton, A.A., Yarov-Yarovoy, V., Yamoah, E.N. & 
Chiamvimonvat, N. 2014. Functional interaction with filamin A and intracellular Ca2+ 
enhance the surface membrane expression of a small-conductance Ca2+-activated K+ 
(SK2) channel. Proc Natl Acad Sci U S A, 111, 9989–9994. 
Smeda, J.S. & McGuire, J.J. 2007. Effects of poststroke Losartan versus Captopril treatment 
on myogenic and endothelial function in the cerebrovasculature of SHRsp. Stroke 38, 1590–
1596. 
Spector, I., Shochet, N.R., Blasberger, D. & Kashman, Y. 1989. Latrunculins--novel marine 
macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with 
cytochalasin D. Cell Motil Cytoskeleton 13, 127–144. 
Wakatsuki, T., Schwab, B., Thompson, N.C. & Elson, E.L. 2001. Effects of cytochalasin D 
and latrunculin B on mechanical properties of cells. J Cell Sci 114, 1025–1036. 
Yasmin, W., Strynadka, K.D. & Schulz, R. 1997. Generation of peroxynitrite contributes to 
ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 33, 422–432. 
Yu, S., Liebeskind, D.S., Dua, S., Wilhalme, H., Elashoff, D., Qiao, X.J., Alger, J.R., 
Sanossian, N., Starkman, S., Ali, L.K., Scalzo, F., Lou, X., Yoo, B., Saver, J.L., Salamon, N. 
& Wang, D.J. et al. 2015. Postischemic hyperperfusion on arterial spin labeled perfusion MRI 
is linked to hemorrhagic transformation in stroke. J Cereb Blood Flow Metab 35, 630–637.  
 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Legends to figures 
 
Figure 1. Relaxation to SLIGRL (20 μmol L-1) in U46619 (30-100 nmol L-1)-preconstricted 
MCA from sham and ischemia/reperfusion (I/R) rats in the presence of l-NAME (300 μmol L-
1) and indomethacin (10 μmol L-1) to isolate EDH-type relaxation in (a) sham and ipsilateral 
(ipsi) or contralateral (contra) to I/R arteries and (b) ipsilateral arteries in the absence and 
presence of the IKCa channel blocker TRAM-34 (1 μmol L-1) or the SKCa channel blocker 
apamin (100 nmol L-1), alone or in combination. (c) Representative tracings showing the 
isolated EDH-type responses evoked by SLIGRL in sham and I/R arteries. Data are shown 
as mean ± SEM from 13 sham, 9 ipsilateral I/R and 8 contralateral I/R arteries (a) or 12 
sham control, 5 sham + TRAM-34, 5    sham + apamin, 6 sham + TRAM-34 + apamin, 8 I/R 
control, 8 I/R + TRAM-34, 3 I/R + apamin and 7 I/R + TRAM-34 + apamin arteries (b) of 
different animals. *P < 0.05; **P < 0.01 vs. sham; †P < 0.05, ††P < 0.01, †††P < 0.001 vs. 
control; ‡‡P < 0.01 vs. TRAM-34, by one (a) or two (b)-way ANOVA with Tukey’s post-test. 
 
Figure 2. Protein expression in an endothelial cell model of hypoxia/reoxygenation (H/R). (a) 
Western blot and densitometric analyses (bottom), normalized to the expression of GAPDH, 
of hypoxia-inducible factor 1 (HIF-1) expression and (b) pull-down assay (immunoblot) of 
Rho-mediated signal activation and densitometric analyses (bottom), normalized to total 
RhoA, in human microvascular endothelial cells exposed to H/R in the absence and 
presence of U46619 (100 nmol L-1). Data are shown as mean ± SEM from 6 independent 
experiments obtained in two batches of cells at different passages. ***P < 0.001 vs. control 
by Student's t-test (a); *P < 0.05, ***P < 0.001 vs. non-treated or ††P < 0.01 vs. control + 
U46619 by two-way ANOVA with Tukey’s post-test (b). 
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Figure 3. SKCa channel expression. (a) Western blot and densitometric analyses (bottom), 
normalized to the expression of GAPDH, of SKCa channel expression in human 
microvascular endothelial cells exposed to hypoxia/reoxygenation (H/R) in the absence and 
presence of U46619 (100 nmol L-1). Data are shown as mean ± SEM from 6 independent 
experiments obtained in two batches of cells at different passages. (b) Representative 
photomicrographs of SKCa channel immunofluorescence (red) of confocal microscopic 
sections of human microvascular endothelial cells exposed to H/R (n = 4 independent 
experiments obtained in two batches of cells at different passages). Filamentous (F)-actin 
staining (green) is also shown. (c) Representative photomicrographs of SKCa channel 
immunofluorescence (red) of confocal microscopic MCA sections of rats submitted to 
ischemia/reperfusion (I/R; n = 4 arteries of different animals per group). Natural 
autofluorescence of elastin (green) and nuclear staining (blue) are also shown. EC, 
endothelial cell; AC, adventitial cell.  
 
Figure 4. Analysis of endothelial cell actin expression. (a) Representative photomicrographs 
of filamentous (F)- (red) and globular (G)-actin (green) immunofluorescence of confocal 
microscopic sections and (b) immunoblot and densitometric analyses (right) of F- relative to 
G-actin expression in human microvascular endothelial cells exposed to 
hypoxia/reoxygenation (H/R) or peroxynitrite (ONOO-; 500 nmol L-1). Nuclear staining (blue) 
is also shown. Data are shown as mean ± SEM from 4-6 independent experiments obtained 
in two batches of cells at different passages. ***P < 0.001 vs. control non-treated by one-way 
ANOVA with Tukey’s post-test. (c) Representative raw (left) and mask (right) 3D 
reconstructions and quantification of F-actin fluorescence (red) in confocal microscopic intact 
MCA stacks of serial optical slices of the endothelial layer of rats submitted to 
ischemia/reperfusion (I/R) or non-operated (control) rats incubated with cytochalasin D 
(CytD; 50 nmol L-1) or ONOO- (5 μmol L-1). Nuclear staining (blue) is also shown. Cuboid 
regions of interest are marked with a dotted white line. EC, endothelial cell; SMC, smooth 
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muscle cell. Data are shown as mean ± SEM from 4 sham, 3 I/R, 4 control + CytD and 4 
control + ONOO- arteries of different animals. *P < 0.05 vs. sham by one-way ANOVA with 
Tukey’s post-test.  
 
Figure 5. Effect of incubation with actin cytoskeleton-disrupting agents on endothelium-
dependent relaxation in U46619 (30-100 nmol L-1)-preconstricted MCA from non-operated 
(control) rats in the presence of l-NAME (300 μmol L-1) and indomethacin (10 μmol L-1) to 
isolate EDH-type relaxation. (a) Concentration-dependent effects of latrunculin B (10 nmol L-
1-1 μmol L-1) on SLIGRL (20 μmol L-1) relaxation. (b) Effects of cytochalasin D (CytD; 50 
nmol L-1) on SLIGRL relaxation in the absence and presence of TRAM-34 (1 μmol L-1) or 
apamin (100 nmol L-1), alone or in combination. (c) Representative tracings (upper panels) 
and analysis (bottom panel) of SKCa channel-mediated relaxation induced by the selective 
SKCa channel activator CyPPA (100 μmol L-1) in control or CytD-incubated arteries in the 
absence and presence of apamin. Data are shown as mean ± SEM from 6 control, 6 control 
+ latrunculin B (10 nmol L-1), 5 control + latrunculin B (100 nmol L-1) and 5 control + 
latrunculin B (1 µmol L-1) (a) or 8 control, 5 control + CytD, 6 control + CytD + TRAM-34, 5 
control + CytD + apamin and 6 control + CytD + TRAM-34 + apamin (b) or 10 control, 7 
control + apamin, 7 control + CytD and 8 control + CytD + apamin (c) arteries of different 
animals. *P < 0.05, **P < 0.01 vs. control; ††P < 0.01, †††P < 0.001 vs. control + CytD by one-
way ANOVA with Tukey’s post-test. 
 
Figure 6. Detection of protein tyrosine nitration. (a) Representative photomicrographs and 
quantification of nitrotyrosine immunofluorescence (red) of confocal microscopic sections 
and (b) Western blot and densitometric analyses (bottom), normalized to the expression of 
GAPDH, of nitrotyrosine expression in human microvascular endothelial cells exposed to 
hypoxia/reoxygenation (H/R) or peroxynitrite (ONOO-; 500 nmol L-1). Filamentous (F)-actin 
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(green) and nuclear staining (blue) are also shown. Representative examples of elevated 
nitrotyrosine immunofluorescence are indicated with arrows. Data are shown as mean ± 
SEM from 6 independent experiments obtained in two batches of cells at different passages. 
***P < 0.001 vs. control by one-way ANOVA with Tukey’s post-test. (c) Representative 
photomicrographs of nitrotyrosine immunofluorescence (red) of confocal microscopic MCA 
sections of rats submitted to ischemia/reperfusion (I/R) or MCA of non-operated (control) 
rats incubated with ONOO- (5 μmol L-1; n = 3 arteries of different animals per group). Natural 
autofluorescence of elastin (green) and nuclear staining (blue) are also shown. Nitro, 
nitrotyrosine; EC, endothelial cell.  
 
Figure 7. Effect of peroxynitrite (ONOO-; 5 μmol L-1) on endothelium-dependent relaxation in 
U46619 (30-100 nmol L-1)-preconstricted MCA from non-operated (control) rats (a, b, c) or 
from sham and ischemia/reperfusion (I/R) rats (d, e) in the presence of l-NAME (300 μmol L-
1) and indomethacin (10 μmol L-1) to isolate EDH-type relaxation. (a) Effects of ONOO- on 
SLIGRL (20 μmol L-1) relaxation in the presence of the oxidation/nitration blocker epicatechin 
(EPICAT; 1 μmol L-1) or the actin filament stabilizer jasplakinolide (JASPK; 100 nmol L-1). 
The effect of decomposed ONOO- (DC-ONOO-; 5 μmol L-1) is also shown. (b) Effects of 
ONOO- on SLIGRL relaxation in the absence and presence of TRAM-34 (1 μmol L-1) or 
apamin (100 nmol L-1), alone or in combination. (c) Representative tracings (upper panels) 
and analysis (bottom panel) of SKCa channel-mediated relaxation induced by CyPPA (100 
μmol L-1) in control, ONOO- or DC-ONOO--incubated arteries. (d) Effect of in vivo treatment 
with the ONOO- decomposition catalyst FeTPPS (20 mg kg-1) on SLIGRL-evoked EDH-type 
relaxation in the absence and presence of TRAM-34 or TRAM-34 plus apamin. (e) Effect of 
in vivo treatment with FeTPPS on SKCa channel-mediated relaxation to CyPPA in the 
absence and presence of apamin. Data are shown as mean ± SEM from 7 control, 7 control 
+ ONOO-, 4 control + DC-ONOO-, 6 control + ONOO- + EPICAT and 5 control + ONOO- + 
JASPK (a) or 6 control, 6 control + ONOO-, 5 control + ONOO- + TRAM-34, 6 control + 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
ONOO- + apamin and 4 control + ONOO- + TRAM-34 + apamin (b) or 9 control, 7 control + 
ONOO- and 3 control + DC-ONOO- (c) or 7 sham + vehicle control, 7 sham + vehicle + 
TRAM-34, 5 sham + vehicle + TRAM-34 + apamin, 7 I/R + vehicle control, 5 I/R + vehicle + 
TRAM-34, 5 I/R + vehicle + TRAM-34 + apamin, 7 I/R + FeTPPS control, 6 I/R + FeTPPS + 
TRAM-34 and 7 I/R + FeTPPS + TRAM-34 + apamin (d) or 8 sham + vehicle, 6 I/R + 
vehicle, 3 I/R + vehicle + apamin and 5 I/R + FeTPPS (e) arteries of different animals. **P < 
0.01 vs. control or vs. sham + vehicle; †P < 0.05, ††P < 0.01, †††P < 0.001 vs. control + 
ONOO- or vs. non-treated; #P < 0.05, ##P < 0.01 vs. I/R + vehicle; ‡P < 0.05; ‡‡‡P < 0.001 vs. 
control + ONOO- + TRAM-34 or vs. I/R + vehicle + TRAM-34, by one (a, b, c, e) or two (d)-
way ANOVA with Tukey’s post-test.  
 
Supporting Information 
Additional Supporting Information may be found online in the supporting information tab for 
this article: 
Table S1. Differences (Δ) in basal tone measured before and after (30 min) addition of 
drugs. 
Table S2. Body weight, body temperature and percentage changes in cortical cerebral blood 
flow (CBF), with respect to basal values, in rats submitted to ischemia (90 min)/reperfusion 
(24 h) (I/R) and treated with 5,10,15,20-tetrakis(4-sulfonatophenyl)prophyrinato iron (III) 
(FeTPPS) or vehicle. 
Figure S1. Concentration-dependent relaxation to bradykinin in U46619 (30-100 nmol L-1)-
preconstricted MCA from sham and ischemia/reperfusion (I/R) rats in the presence of l-
NAME (300 µmol L-1) and indomethacin (10 µmol L-1) to isolate endothelium-derived 
hyperpolarization-type response. Data are shown as mean ± SEM from 8 sham and 6 I/R 
arteries of different animals 
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Figure S2. Representative hypoxia-inducible factor 1α (HIF-1α) Western blot results in 
human microvascular endothelial cells exposed to hypoxia/reoxygenation (H/R) or 
peroxynitrite (ONOO-; 500 nmol L-1).   
Figure S3. Representative SKCa channel Western blot results in human microvascular 
endothelial cells exposed to hypoxia/reoxygenation (H/R) in the absence and presence of 
U46619 (100 nmol L-1). 
Figure S4. Representative nitrotyrosine Western blot results in human microvascular 
endothelial cells exposed to hypoxia/reoxygenation (H/R) or peroxynitrite (ONOO-; 500 nmol 
L-1).   
Figure S5. Spectrophotometric analysis of peroxynitrite (2 µmol L-1) oxidant activity and its 
decay after decomposition. Consumption of pyrogallol red (6 µmol L-1) by peroxynitrite, 
submitted or not to different conditions, was evaluated in the presence of diphenyl 
diselenide. Data are shown as mean ± SEM from 3 independent experiments per group. *P 
< 0.05 vs. no degradation, by two-way ANOVA. 
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